tm
Seeing Is Believing
tm
Seeing Is Believing
GPCR is currently covered by 8 analysts with an average price target of $100.63. This is a potential upside of $42.06 (158.36%) from yesterday's end of day stock price of $38.95.
Structure Therapeutics American Depositary Shares's activity chart (see below) currently has 68 price targets and 70 ratings on display. The stock rating distribution of GPCR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 72.92% with an average time for these price targets to be met of 332.08 days.
Highest price target for GPCR is $140, Lowest price target is $65, average price target is $100.63.
Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 09-Sep-2026. First documented stock forecast 27-Feb-2023.
Currently out of the existing stock ratings of GPCR, 15 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Oct-2023
$110
$71.34 (184.53%)
$110
7 days ago
(09-Sep-2026)
9/12 (75%)
$68.77 (166.80%)
530
Buy Since 02-May-2025
$97
$58.34 (150.91%)
$100
1 months 9 days ago
(07-Aug-2026)
1/3 (33.33%)
$43.86 (82.54%)
220
Buy Since 20-Dec-2024
$70
$20.29 (40.82%)
$100
3 months 5 days ago
(11-Jun-2026)
3/6 (50%)
$26.7 (61.66%)
229
Buy Since 21-May-2024
$105
$55.29 (111.23%)
$65
7 months 25 days ago
(22-Jan-2026)
1/2 (50%)
$13.13 (14.29%)
566
Buy Since 28-Feb-2023
$140
$90.29 (181.63%)
$90
7 months 27 days ago
(20-Jan-2026)
2/3 (66.67%)
$48.98 (53.81%)
190
What is GPCR (Structure Therapeutics American Depositary Shares) average time for price targets to be met?
Which analyst most recently updated their price target on GPCR (Structure Therapeutics American Depositary Shares)?
Which analyst has the most public recommendations on GPCR (Structure Therapeutics American Depositary Shares)?
Which analyst is the currently most bullish on GPCR (Structure Therapeutics American Depositary Shares)?
Which analyst is the currently most reserved on GPCR (Structure Therapeutics American Depositary Shares)?
